Nothing Special   »   [go: up one dir, main page]

PRICE SURVEY - Vaccines Pricing Audit Indonesia

Download as xlsx, pdf, or txt
Download as xlsx, pdf, or txt
You are on page 1of 10

PLEASE COMPLETE BOTH PART A & PART B OF THE SURVEY

INSTRUCTIONS:
PART A:
1) Please review the list of vaccines and add any other vaccine brands that are approved in your country for th
2) If a vaccine is publicly funded as a part of your country's national immunization program (NIP), please fill in t
(Column G)
3) If a vaccine is privately funded, please fill in the ex-factory price, distributor price, and retail price (Columns
4) Please include any comments / detailed rationale in the additional notes section, including any rationale if p
not distributed, vaccine discontinued, vaccine replaced by another brand)
PART B:
1) Please scroll to the bottom of the spreadsheet and use the free text section to detail any price adjustment p
market (e.g., frequency of adjustment, public / private sector applicability, % price increase permitted)

PART A

COUNTRY VACCINE TYPE

IDN Dengue Fever


IDN Human Papillomavirus (HPV)
IDN Human Papillomavirus (HPV)
IDN Human Papillomavirus (HPV)
IDN Japanese Encephalitis
IDN Meningococcal
IDN Meningococcal
IDN Meningococcal
IDN Pneumococcal
IDN Pneumococcal
IDN Pneumococcal
IDN Rotavirus
IDN Rotavirus
IDN Yellow Fever

PART B
Please detail any price adjustment policies related to vaccines in your market here (e.g., frequency of adjustme
Please detail any price adjustment policies related to vaccines in your market here (e.g., frequency of adjustme
BOTH PART A & PART B OF THE SURVEY

brands that are approved in your country for the outlined disease areas
tional immunization program (NIP), please fill in the public procurement price

price, distributor price, and retail price (Columns H, I and J)


ditional notes section, including any rationale if prices are unavailable (e.g., vaccine
other brand)

free text section to detail any price adjustment policies related to vaccines in your
applicability, % price increase permitted)

VACCINE PRICING AUDIT IN INDONESIA

BRAND NAME MFG

DENGVAXIA SANOFI
CERVARIX GSK
GARDASIL MERCK
GARDASIL 9 MERCK
IMOJEV SANOFI
MENVEO GSK
MENCENVAX GSK
MENACTRA SANOFI
PNEUMOVAX 23 MERCK
PREVNAR 13 PFIZER
SYNFLORIX GSK
ROTARIX GSK
ROTATEQ MERCK
STAMARIL SANOFI

in your market here (e.g., frequency of adjustment, public / private sector applicability, % price increase permitted)
DEFINITIONS:
PUBLIC PROCUREMENT PRICE: The price that governments pay
manufacturers for vaccine purchase
EX-FACTORY PRICE: The price that distributors pay manufacturers for
vaccine purchase
DISTRIBUTOR PRICE: The price that distributors sell the vaccines to
private clinics, adding a profit
RETAIL PRICE: The price that clinics charge patients for vaccines

VACCINE PRICING AUDIT IN INDONESIA


PUBLIC PROCUREMENT PRICE EX-FACTORY PRICE
(PER DOSE, IDR) (PER DOSE, IDR)

r applicability, % price increase permitted)


RICE: The price that governments pay
e purchase
price that distributors pay manufacturers for

price that distributors sell the vaccines to


rofit
hat clinics charge patients for vaccines

DISTRIBUTOR PRICE RETAIL PRICE


(PER DOSE, IDR) (PER DOSE, IDR)
1,320,000
990,000
1,250,000
1,100,000
650,000
575,000
300,000
890,000
500,000
1,048,000
750,000
528,327
450,000
869,000
ADDITIONAL NOTES

You might also like